University of Maryland, College Park
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University of Maryland, College Park sits in the top decile of US sponsors by registered trial count (#393 of 15,742 sponsors by registered trial count).
University of Maryland, College Park: 46 sponsored US clinical trials, 10 recruiting.
University of Maryland, College Park sponsors 46 registered US clinical trials on ClinicalTrials.gov, 10 of them currently recruiting, and 34 completed. 3 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Substance-Related Disorders, with 2 trials.
Top-decile sponsor footprint
University of Maryland, College Park ranks in the top decile of sponsors by registered trial count (#393 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
34 of 34 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
46 total, page 1 of 1
Using the Smart Underwear Device to Determine a Baseline of Flatus Activity Normalized to Fiber Intake
NCT07134543
Effects of Youth Mental Health First Aid (YMHFA) on South Asian American Adults Working With South Asian American Youth
NCT07135479
Testing the Capability of the Smart Underwear Device to Detect Increased Microbiome Activity Following Lactose Consumption
NCT06724705
Neurocognitive Mechanisms of Sentence Production Impairment in Aphasia
NCT06405594
Longitudinal Investigation of Sleep, Memory, and Brain Development Across the Nap Transition
NCT06351098
Rosie the Chatbot: Leveraging Automated and Personalized Health Information Communication
NCT06053515
An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)
NCT06058455
Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
NCT05973838
Hands and Hearts Together
NCT05834907
Speech Perception and High Cognitive Demand
NCT04997577
Treating Parents with ADHD and Their Young Children Via Telehealth: a Hybrid Type I Effectiveness-Implementation Trial
NCT04240756
Evaluating Modes of Influenza Transmission 2b Baseline SAR
NCT07342556
How Clinical and Personal Information Shape Physicians' Risk Judgments
NCT07162376
Gut Microbial Metabolites of Apple Polyphenols
NCT06107192
A Chatbot Intervention for Reducing HPV Vaccine Hesitancy
NCT05959564
Developing Inclusive Youth: Promoting Intergroup Friendships and Inclusive Classrooms in Childhood
NCT05619523
Peer Activate: Trial of Peer-Delivered Behavioral Activation for Methadone Adherence
NCT05299515
Speech Perception With High Cognitive Demand
NCT04698356
SAVA Syndemic Risk Reduction for African American Couples
NCT04766697
A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination
NCT03856437
Peer-Delivered Behavioral Activation for Methadone Adherence - Pilot Phase
NCT04248933
Tailoring Mindfulness Interventions for Families Managing Chronic Health Conditions
NCT05271851
Exercise for Brain Health in the Fight Against Alzheimer's Disease
NCT03727360
School-Based Depression Prevention for Adolescents With ADHD
NCT04104841
Effectiveness & Implementation of a Behavioral Intervention for Adherence and Substance Use in HIV Care in South Africa
NCT03529409
Neuroplasticity in Auditory Aging_Project 2 Aims 1 and 2
NCT03475043
Auditory Temporal Processes in Aging
NCT03468660
Integration of Cancer Health Activities Into African American Churches
NCT03178383
Helping College Students With ADHD Lead Healthier Lifestyles
NCT02829970
Changing Impulsivity With Mindful Breathing Therapy to Reduce Problem Drinking
NCT02527720
Writing About Experiences With Ovarian Cancer
NCT02593422
Multi-Component Early Intervention for Socially Inhibited Preschool Children
NCT02308826
Evaluating Behavioral Activation Efficacy in Depressed Spanish-Speaking Latinos
NCT01958840
Evaluating Modes of Influenza Transmission Observational Study of Community Acquired Influenza
NCT01769430
Men's Prostate Awareness Church Training
NCT02131779
Behavioral Intervention for Low Income Depressed Smokers in Drug Treatment
NCT01372254
Implementation of Evidence-Based Cancer Early Detection in Black Churches
NCT02076958
Behavioral Activation Intervention for Smoking Cessation in Smokers With Depressive Symptoms
NCT01199380
Nonconvulsive Electrotherapy: a Proof-of-concept Trial
NCT01065597
Behavioral Activation Intervention, Reward Processing, and Youth Smoking Cessation
NCT01351766
A Multi-Method Early Intervention Program for Inhibited and Anxious Preschoolers
NCT03486860
Anxiety Sensitivity Treatment for Heroin Users
NCT01196312
Primary Prevention of Major Depression in Later Life
NCT00326677
Integrated Parent Training for Treating Depression in Mothers of Children With Attention Deficit Hyperactivity Disorder
NCT00316290
Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD
NCT00318981
Gene - Exercise Research Study
NCT00976742
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 3 | 2 |
| Phase 4 | 1 |
What is open in the University of Maryland, College Park pipeline
10 recruiting of 46 indexed (22% open); 34 completed (74%).
Phase mix: 3 late (III/IV) vs 3 early (I/II) (balanced across stages).
Top condition: Substance-Related Disorders (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Maryland, College Park: open-pipeline peers nationwide
Peers matched on 46 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
University of Maryland, College Park sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 46 trials (± recruiting share)
- Baxter Healthcare Corporation · 46 trials · 2% recruiting
- ImmunityBio · 46 trials · 17% recruiting
- National Institute of Nursing Research (NINR) · 46 trials · 0% recruiting
- New York Medical College · 47 trials · 34% recruiting
Sponsors near 22% open enrollment (± trial volume)
- AtriCure · 22% recruiting · 23 trials
- University of Colorado, Boulder · 22% recruiting · 69 trials
- Regeneron Pharmaceuticals · 22% recruiting · 280 trials
- Henry M. Jackson Foundation for the Advancement of Military Medicine · 22% recruiting · 60 trials
Related
What to do with this University of Maryland, College Park page
46 registered trials is a research-attention snapshot, not an endorsement of University of Maryland, College Park or any single study.
- 10 of University of Maryland, College Park's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Substance-Related Disorders is the condition University of Maryland, College Park studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Substance-Related Disorders trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Maryland, College Park pipeline card: 46 registered trials from official public datasets.Report a data error.